Compare POCI & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | POCI | NBY |
|---|---|---|
| Founded | 1982 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.7M | 31.6M |
| IPO Year | 2008 | 2007 |
| Metric | POCI | NBY |
|---|---|---|
| Price | $4.25 | $1.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 33.4K | ★ 351.9K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.42 |
| EPS | N/A | ★ 0.76 |
| Revenue | ★ $19,091,269.00 | $370,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.57 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.55 | $0.43 |
| 52 Week High | $6.04 | $19.95 |
| Indicator | POCI | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 49.15 | 57.82 |
| Support Level | $3.96 | $1.01 |
| Resistance Level | $4.83 | $2.52 |
| Average True Range (ATR) | 0.27 | 0.26 |
| MACD | -0.00 | 0.11 |
| Stochastic Oscillator | 33.82 | 96.45 |
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.